Marion McCourt, EVP Commercial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 546 shares at $945.61 ($516K) on 2024-02-01, disclosed to the SEC on 2024-02-02.
Scheduled sale ($516k) by EVP Commercial under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $945.61 | 273 | $258K | 50.0% |
| 2 | $945.61 | 273 | $258K | 50.0% |
| Total | $945.61 avg | 546 | $516K | 100% |
| Filing → |
| REGN | SELL | 2024-10-03 | $1.1M | — | Filing → |
| REGN | SELL | 2024-09-05 | $1.2M | — | Filing → |
| REGN | SELL | 2024-08-05 | $2.4M | — | Filing → |